NARI Inari Medical, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

NARI [NASD]

Inari Medical, Inc.

Healthcare | Medical Devices | USA

statements

Index	-	P/E	770.00	EPS (ttm)	0.08	Insider Own	4.60%	Shs Outstand	50.14M	Perf Week	12.25%
Market Cap	3.24B	Forward P/E	-	EPS next Y	-0.37	Insider Trans	0.00%	Shs Float	30.55M	Perf Month	36.03%
Income	3.90M	PEG	-	EPS next Q	-0.18	Inst Own	41.80%	Short Float	0.41%	Perf Quarter	-
Sales	71.10M	P/S	45.61	EPS this Y	88.30%	Inst Trans	-	Short Ratio	0.26	Perf Half Y	-
Book/sh	-	P/B	-	EPS next Y	0.00%	ROA	-	Target Price	53.67	Perf Year	-
Cash/sh	0.65	P/C	100.09	EPS next 5Y	-	ROE	-	52W Range	39.55 - 65.49	Perf YTD	52.15%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-3.00%	52W High	-1.24%	Beta	-
Dividend %	-	Quick Ratio	5.50	Sales past 5Y	-	Gross Margin	89.20%	52W Low	63.54%	ATR	4.03
Employees	240	Current Ratio	6.10	Sales Q/Q	291.30%	Oper. Margin	8.60%	RSI (14)	70.10	Volatility	7.59% 8.47%
Optionable	No	Debt/Eq	-	EPS Q/Q	533.50%	Profit Margin	5.40%	Rel Volume	0.68	Prev Close	64.61
Shortable	Yes	LT Debt/Eq	-	Earnings	Aug 11 AMC	Payout	0.00%	Avg Volume	483.43K	Price	64.68
Recom	2.30	SMA20	17.47%	SMA50	27.32%	SMA200	27.73%	Volume	332,379	Change	0.11%

Jun-19-20

Initiated

Canaccord Genuity

Buy

Jun-16-20

Initiated

Wells Fargo

Equal Weight

$49

Jun-16-20

Initiated

Morgan Stanley

Equal-Weight

$52

Jun-16-20

Initiated

BofA/Merrill

Neutral

$56

Jul-29-20 04:01PM	Inari Medical to Present at the Canaccord Genuity 40th Annual Growth Conference GlobeNewswire
Jul-28-20 04:01PM	Inari Medical to Announce Second Quarter 2020 Financial Results GlobeNewswire
Jul-24-20 10:06AM	Inari Medical (NARI): Strong Growth And Abundant Potential Insider Monkey
Jun-15-20 04:43PM	Why You Need This Medical-Device Company on Your Radar Motley Fool
Jun-02-20 09:30AM	Inceptus Announces IPO Of First Portfolio Company PR Newswire
May-27-20 12:48PM	Inari Medical Announces Closing of Initial Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares GlobeNewswire
May-22-20 12:40PM	Inari Medical shares soar in IPO Yahoo Finance Video
12:17PM	Inari Medical's stock blasts off, trades more than double the IPO price MarketWatch
06:42AM	Inari Medical increases shares it sold in IPO, which priced above the expected range MarketWatch
May-21-20 10:48PM	Inari Medical Announces Pricing of Its Upsized Initial Public Offering GlobeNewswire

Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It produces ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience